v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2025
Dec. 31, 2024
Current Assets    
Cash and cash equivalents $ 902 $ 781
Accounts receivable - net of allowance for doubtful accounts of $1 329 360
Inventories 331 315
Other current assets 109 82
Total Current Assets 1,671 1,538
Marketable securities 23 11
Property, plant and equipment, net 834 803
Intangible assets, net 816 822
Goodwill 2,075 2,075
Other non-current assets 98 87
TOTAL ASSETS 5,517 5,336
Current Liabilities    
Accounts payable 192 212
Product warranty liability 34 31
Current portion of long-term debt 5 5
Deferred revenue 35 41
Other current liabilities 172 217
Total Current Liabilities 438 506
Product warranty liability 47 36
Deferred revenue 101 95
Long-term debt 2,393 2,395
Deferred income taxes 545 501
Other non-current liabilities 152 152
TOTAL LIABILITIES 3,676 3,685
Commitments and contingencies (see Note P)
STOCKHOLDERS’ EQUITY    
Preferred stock, $0.01 par value, 100,000,000 shares authorized, none issued and outstanding 0 0
Paid in capital 1,953 1,940
Accumulated deficit (70) (239)
Accumulated other comprehensive loss, net of tax (43) (51)
TOTAL STOCKHOLDERS’ EQUITY 1,841 1,651
TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY 5,517 5,336
Voting Common Stock    
STOCKHOLDERS’ EQUITY    
Common stock 1 1
Non-voting Common Stock    
STOCKHOLDERS’ EQUITY    
Common stock $ 0 $ 0